Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and Metabolite Study of [14C]OD-001 in Healthy Male Participants
NCT07900607Phase 1Recruiting
- Start
- Oct 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of OD001. Primary endpoints: Cumulative Amount Excreted, Cumulative Percentage of Dose Excreted and 2 more. Started Oct 2026; status: recruiting.
02
Drugs
OD001
Beyond the preview
Go deeper on NCT07900607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07900607.